Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Hydrolysable impurity compound of valsartan and preparation method, detection method and use thereof

A detection method and compound technology, applied in the field of medicine, can solve the problems of undisclosed impurity preparation methods and structural confirmation data, undisclosed application of hydrolyzed impurities, etc., to achieve good control and improve quality standards

Inactive Publication Date: 2014-10-01
NANJING CHIA TAI TIANQING PHARMA
View PDF5 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The literature on valsartan is quite rich, mainly focusing on the synthesis route and crystal form. Regarding the impurity control of valsartan, Chinese patent CN102670485B discloses the preparation method of the solid composition of valsartan, and the hydrolyzed impurity H However, the patent does not disclose the preparation method of the impurity and the data on the confirmation of the structure, nor does it disclose the application of the hydrolyzed impurity as an impurity reference substance in the inspection of related substances in valsartan

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Hydrolysable impurity compound of valsartan and preparation method, detection method and use thereof
  • Hydrolysable impurity compound of valsartan and preparation method, detection method and use thereof
  • Hydrolysable impurity compound of valsartan and preparation method, detection method and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] Embodiment 1 Preparation of valsartan hydrolysis impurity compound

[0040] (1) Get 30g of valsartan, dissolve it in 200ml of acetonitrile, add 200ml of 6mol / L hydrochloric acid, heat and reflux for 4 hours, stir and drop to room temperature, then add 50% NaOH aqueous solution to adjust pH to neutral, separate phases, Add NaCl to the obtained aqueous phase to become a saturated solution, filter, extract the obtained saturated aqueous solution with n-butanol, take the organic phase, and evaporate to dryness to obtain a white solid;

[0041] (2) Dry the white solid in a vacuum drying oven, then beat with 10 times the weight of water at room temperature for 2 hours, and filter with suction to obtain the pure product. Through DEPT spectrum, COZY spectrum, HMBC, 1 H-NMR spectrum, 13 The structure was confirmed by C-NMR spectrum, and the analyzed data are shown in Table 1.

Embodiment 2

[0042] Embodiment 2 Preparation of valsartan hydrolysis impurity compound

[0043] (1) Get 30g of valsartan, dissolve it in 200ml of acetonitrile, add 300ml of 4mol / L hydrochloric acid, heat and reflux for 5 hours, stir and drop to room temperature, then add 60% NaOH aqueous solution to adjust pH to neutral, separate phases, Add NaCl to the obtained aqueous phase to become a saturated solution, filter, extract the obtained saturated aqueous solution with n-butanol, take the organic phase, and evaporate to dryness to obtain a white solid;

[0044] (2) Dry the white solid in a vacuum drying oven, then beat with 8 times the weight of water at room temperature for 3 hours, and filter with suction to obtain the pure product. Through DEPT spectrum, COZY spectrum, HMBC, 1 H-NMR spectrum, 13 The structure was confirmed by C-NMR spectrum, and the analyzed data are shown in Table 1.

Embodiment 3

[0045] Embodiment 3 Preparation of valsartan hydrolysis impurity compound

[0046](1) Get 30g of valsartan, dissolve it in 200ml of acetonitrile, add 140ml of 9mol / L hydrochloric acid, heat and reflux for 3 hours, stir and drop to room temperature, then add 40% NaOH aqueous solution to adjust pH to neutral, separate phases, Add NaCl to the obtained aqueous phase to form a saturated solution, filter, extract the obtained saturated aqueous solution with n-butanol, take the organic phase, and evaporate to dryness to obtain a white solid;

[0047] (2) Dry the white solid in a vacuum drying oven, then beat with 12 times the weight of water at room temperature for 1 hour, and filter to obtain the pure product. Through DEPT spectrum, COZY spectrum, HMBC, 1 H-NMR spectrum, 13 The structure was confirmed by C-NMR spectrum, and the analyzed data are shown in Table 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a hydrolysable impurity compound of valsartan, and discloses a preparation method and a detection method of the hydrolysable impurity compound, and use of the hydrolysable impurity compound for serving as an impurity reference substance for determination of valsartan related substances. Through preparation and structural confirmation of the compound, the reference substance is provided for analysis of the valsartan related substances, so as to improve the quality standard of valsartan, and provide important guiding significance for safe medication of valsartan.

Description

technical field [0001] The invention belongs to the technical field of medicine, and relates to a hydrolyzed impurity compound of valsartan, a preparation method, a detection method and application thereof. Background technique [0002] Valsartan (valsartan), chemical name: N-(1-oxopentyl)-N-[4-[2-(1H-tetrazol-5-yl)phenyl]benzyl]-L-valine , whose chemical formula is shown in formula Ⅱ, is an angiotensin receptor antagonist with a brand-new antihypertensive mechanism, stable antihypertensive, strong curative effect, long action time, and good tolerance of patients. Brain and kidney have a better protective effect. Patients with hypertension such as myocardial infarction, heart failure, proteinuria, and diabetes can be used as a conventional drug, and can also be used in combination with diuretics (such as hydrochlorothiazide). [0003] [0004] The literature on valsartan is quite rich, mainly focusing on the synthesis route and crystal form. Regarding the impurity contro...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D257/04G01N30/02
CPCC07D257/04G01N30/02
Inventor 钱修文吴舰朱谧柴雨柱杨治旻
Owner NANJING CHIA TAI TIANQING PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com